10% Free customization
The Laboratory Equipment and Disposables industry is a cornerstone of modern scientific research, diagnostics, and quality control across diverse sectors including healthcare, pharmaceuticals, biotechnology, food and beverage, academic research, and industrial testing. This industry encompasses a vast range of tools and materials essential for laboratory operations ranging from high-end analytical instruments like centrifuges, spectrometers, and autoclaves to everyday consumables such as pipettes, petri dishes, gloves, test tubes, and culture media. The sector has witnessed substantial growth in recent years, driven primarily by the rising demand for clinical diagnostics, life sciences research, and environmental testing. This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
1h Free Analyst TimeSpeak directly to the analyst to clarify any post sales queries you may have.
With advancements in biotechnology and genomics, and the growing incidence of chronic diseases and infectious outbreaks like COVID-19, laboratories across the world have seen increased demand for reliable, high-throughput equipment and sterile, single-use disposables that ensure both precision and safety in testing. One of the key strengths of this industry lies in its dual structure equipment forms the long-term capital investment side, while disposables fuel continuous revenue through regular replenishment.
According to the research report “Global Laboratory Equipment and Disposables Market Outlook, 2030” the global Laboratory Equipment and Disposables market is projected to reach market size of USD 67.01 Billion by 2030 increasing from USD 46.12 Billion in 2024, growing with 6.56% CAGR by 2025-30. Laboratories, particularly those involved in diagnostic testing and pharmaceutical development, rely heavily on disposable products to maintain sterility, avoid cross-contamination, and comply with increasingly stringent regulatory standards. In fact, the trend toward single-use lab disposables has gained momentum due to their cost-effectiveness, convenience, and critical role in infection control.
Meanwhile, advancements in automated and digitized lab equipment have enhanced lab productivity, reproducibility, and data accuracy. Modern instruments now offer integration with AI and cloud-based data management platforms, which support real-time monitoring, predictive analytics, and remote diagnostics further boosting their appeal in both centralized labs and point-of-care settings. Geographically, North America leads the laboratory equipment and disposables market, owing to its well-established healthcare infrastructure, robust R&D investments, and the presence of major industry players.
The U.S., in particular, benefits from high levels of funding for biomedical research, a strong network of clinical labs, and early adoption of advanced laboratory technologies. However, the Asia-Pacific region is rapidly emerging as a growth engine, spurred by expanding healthcare systems, increasing investments in pharmaceutical and biotech manufacturing, and a rising focus on academic and industrial research. Countries like China, India, and South Korea are scaling up laboratory capabilities to meet growing domestic and global demand, with government and private sector support boosting the infrastructure needed for advanced diagnostics and drug discovery.
Market Drivers
- Rising Demand for Clinical Diagnostics and Disease Surveillance: The growing global burden of chronic and infectious diseases such as diabetes, cancer, and viral outbreaks like COVID-19 has significantly increased the demand for diagnostic testing. This, in turn, drives the need for advanced lab equipment and high-volume disposables like swabs, test tubes, gloves, and reagents in both hospital and private labs. The emphasis on early detection and personalized medicine has further reinforced the role of laboratory infrastructure in modern healthcare.
- Expansion of Pharmaceutical and Biotech R&D Activities: With the rapid growth of the pharmaceutical and biotechnology sectors, especially in drug discovery, vaccine development, and genomic research, laboratories are investing heavily in high-throughput analytical equipment and sterile disposables. This surge in R&D, backed by government grants and private funding, continues to fuel demand for precision instruments, culture media, pipette tips, and other consumables essential for safe and reproducible results.
Market Challenges
- High Cost of Advanced Equipment and Infrastructure: Modern laboratory equipment is technologically sophisticated, often requiring significant capital investment along with trained personnel for operation and maintenance. This poses a barrier for small labs, academic institutions, and research setups in developing countries, where budget constraints limit access to cutting-edge instruments.
- Environmental Concerns Related to Single-Use Plastics: The widespread use of disposable lab products made from non-biodegradable plastics has raised serious environmental concerns. With millions of single-use items discarded daily, regulatory pressures and ethical considerations are compelling the industry to seek sustainable alternatives a challenge in maintaining sterility and performance while reducing ecological impact.
Market Trends
- Integration of Digital Technologies and Lab Automation: Laboratories are increasingly adopting automation, AI, and IoT-driven devices for sample handling, analysis, and data management. Automated pipetting systems, robotic sample processors, and cloud-based data platforms not only enhance speed and accuracy but also reduce human error and support high-volume testing especially valuable during pandemics and mass screening efforts.
- Development of Eco-Friendly and Sustainable Lab Products: To address environmental concerns, manufacturers are innovating biodegradable or recyclable lab disposables and exploring greener production methods. Sustainable packaging, reusable labware, and efforts to minimize energy consumption in equipment are gaining traction as laboratories align with global sustainability goals.
Laboratory equipment holds the dominant share in the Laboratory Equipment and Disposables Market primarily due to its central role in enabling the accurate, reproducible, and high-throughput analysis required across various scientific and diagnostic applications. Whether in clinical diagnostics, pharmaceutical R&D, environmental testing, or academic research, advanced equipment such as centrifuges, incubators, spectrophotometers, autoclaves, and PCR machines form the backbone of laboratory operations. These instruments are not only essential for conducting precise analyses but also ensure compliance with regulatory standards for data integrity and safety.
The ongoing technological evolution marked by automation, digital integration, and AI-powered analytics has significantly enhanced the capabilities of lab equipment, making them more efficient and user-friendly. Additionally, the increasing focus on disease surveillance, personalized medicine, and rapid diagnostics has led to a surge in the demand for cutting-edge equipment in both public and private sector laboratories. Unlike disposables, which are replenished regularly, laboratory equipment involves substantial capital investment and often determines the lab's testing capacity and specialization.
With governments, healthcare systems, and pharmaceutical companies investing heavily in expanding lab infrastructure especially in the wake of the COVID-19 pandemic the demand for high-performance, automated, and scalable laboratory equipment has soared globally. This long-term value and irreplaceable function in core laboratory workflows position equipment as the leading segment in the overall laboratory equipment and disposables market.
The pharmaceutical sector is leading the Laboratory Equipment and Disposables Market because of its continuous need for high-precision testing, stringent regulatory compliance, and heavy investment in research and drug development processes.
Pharmaceutical companies are the primary drivers of demand in the Laboratory Equipment and Disposables Market due to their critical dependence on advanced laboratory infrastructure for activities such as drug discovery, formulation development, quality control, stability testing, and regulatory validation. In this highly regulated industry, every stage of the drug development lifecycle spanning from preclinical trials to post-market surveillance requires rigorous scientific testing, which can only be achieved through accurate, reliable, and repeatable laboratory practices.
This translates into a high and continuous demand for both sophisticated lab equipment (like HPLC systems, mass spectrometers, and incubators) and sterile disposables (like pipette tips, culture media, filters, and vials) to maintain contamination-free workflows and ensure data integrity. The rise of biologics, biosimilars, and personalized medicines has further intensified the need for precise analytical tools and single-use technologies. Additionally, as pharmaceutical companies expand their R&D pipelines and manufacturing capacities to address global health challenges ranging from chronic diseases to infectious outbreaks the scale and complexity of laboratory operations have grown exponentially.
Regulatory frameworks from agencies such as the FDA, EMA, and WHO impose strict standards for laboratory practices, making the investment in high-quality lab tools and disposables non-negotiable. The surge in outsourcing of testing and drug development activities to contract research organizations (CROs) and contract manufacturing organizations (CMOs) has also contributed to the sector's dominance.
North America is leading in the Laboratory Equipment and Disposables Market due to its advanced healthcare infrastructure, strong R&D investment, and the presence of major pharmaceutical and biotech companies.
North America's dominance in the Laboratory Equipment and Disposables Market is largely attributed to its well-established scientific ecosystem, high healthcare spending, and leadership in pharmaceutical and biotechnological innovation. The United States, in particular, houses a dense concentration of clinical laboratories, research institutions, and life science companies that drive consistent demand for cutting-edge laboratory instruments and sterile consumables. The region benefits from substantial investments in medical research and development, supported by government funding through agencies like the National Institutes of Health (NIH) and private sector financing.
This robust funding landscape fuels continuous innovation and the adoption of advanced technologies such as lab automation, molecular diagnostics, and genomics fields that rely heavily on high-precision equipment and contamination-free disposables. Moreover, North America is home to several global leaders in lab equipment and supplies manufacturing, including Thermo Fisher Scientific, Agilent Technologies, and Danaher Corporation, which enables faster innovation cycles and streamlined distribution within the region.
The presence of stringent regulatory standards from bodies like the FDA further necessitates the use of high-quality laboratory tools to meet compliance and safety benchmarks, especially in clinical diagnostics and pharmaceutical development. Additionally, the region's early adoption of personalized medicine and digital health tools has expanded the role of laboratories, increasing the demand for integrated and automated lab systems. The COVID-19 pandemic further accelerated laboratory capacity expansions in North America, driving investments in diagnostics infrastructure, which continues to benefit the market post-pandemic.
- 9 February 2024, Bruker Corporation acquired Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems. Nanophoton offers a broad portfolio of advanced Raman microscopes, serving academic and industrial research individuals, primarily in Japan. This acquisition fills a gap in Bruker’s molecular microscopy portfolio, and it is looking forward for offering fast, flexible, and sensitive Nanophoton Raman microscopy systems worldwide for R&D in the life sciences, biopharma, advanced materials, semiconductors, and polymers.
- 4 December 2023, PerkinElmer, a leading global analytical services and solutions provider, announced that it acquired Covaris, a leading developer of solutions to empower life science innovations. The merger will accelerate Covaris’ growth potential and expand PerkinElmer’s existing life sciences portfolio into the high-growth diagnostics end market. In addition, both companies are majority owned by New Mountain Capital.
Considered in this report
- Historic Year: 2019
- Base year: 2024
- Estimated year: 2025
- Forecast year: 2030
Aspects covered in this report
- Laboratory Equipment and Disposable Market with its value and forecast along with its segments
- Various drivers and challenges
- On-going trends and developments
- Top profiled companies
- Strategic recommendation
By Product Type
- Equipment
- Disposables
By End-User
- Pharmaceuticals
- Hospitals
- Academic/Research
- Biotech
- Industrial
The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases.After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.
Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.Table of Contents
1. Executive Summary5. Economic /Demographic Snapshot13. Strategic Recommendations15. Disclaimer
2. Market Dynamics
3. Research Methodology
4. Market Structure
6. Global Laboratory Equipment and Disposables Market Outlook
7. North America Laboratory Equipment and Disposables Market Outlook
8. Europe Laboratory Equipment and Disposables Market Outlook
9. Asia-Pacific Laboratory Equipment and Disposables Market Outlook
10. South America Laboratory Equipment and Disposables Market Outlook
11. Middle East & Africa Laboratory Equipment and Disposables Market Outlook
12. Competitive Landscape
14. Annexure
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Eppendorf AG
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Nikon Corporation
- Shimadzu Corporation
- PerkinElmer, Inc.
- Sartorius AG
- Ansell Limited
- Corning Incorporated
- Agilent Technologies, Inc.
- Waters Corporation
- Greiner Group AG
- Gilson, Inc.
- Tuttnauer Ltd.
- Yamato Scientific Co., Ltd.
- Systec GmbH & Co. KG
- Sarstedt AG & Co. KG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 165 |
| Published | June 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 46.12 Billion |
| Forecasted Market Value ( USD | $ 67.01 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
